MAGEA9 Antikörper (Middle Region)
Kurzübersicht für MAGEA9 Antikörper (Middle Region) (ABIN927725)
Target
Alle MAGEA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- MAGEA9 antibody was raised in rabbit using the middle region of MAGEA9 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
MAGEA9 Blocking Peptide, (ABIN5614632), is also available for use as a blocking control in assays to test for specificity of this MAGEA9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAGEA9 (Melanoma Antigen Family A, 9 (MAGEA9))
-
Andere Bezeichnung
- MAGEA9
-
Hintergrund
- This pseudogene is a member of the cytochrome P450 gene superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine. This locus is part of a cluster of cytochrome P450 genes on chromosome 22q13.1. Synonyms: Polyclonal MAGEA9 antibody, Anti-MAGEA9 antibody, melanoma antigen family A, 9 antibody, MAGE9 antibody, MGC8421 antibody.
Target
-